Dr Soumya Swaminathan, World Health Organisation (WHO) chief scientist on Sunday informed that WHO's technical advisory group will meet on October 26 to consider emergency use listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin.
Taking to Twitter, Dr Swaminathan said the WHO has been working closely with Bharat Biotech to complete the dossier.
"The technical advisory group will meet on Oct 26th to consider EUL for #Covaxin. @WHO has been working closely with @BharatBiotech to complete the dossier. Our goal is to have a broad portfolio of vaccines approved for emergency use & to expand access to populations everywhere," Dr Swaminathan tweeted.
Covaxin has been submitting data to WHO on a rolling basis and submitted additional information at WHO's request on September 27.
"Covaxin manufacturer, Bharat Biotech, has been submitting data to WHO on a rolling basis & submitted additional info at WHO''s request on 27 September. WHO experts are currently reviewing this info & if it addresses all questions raised, WHO assessment will be finalized next week," WHO had tweeted earlier this month.
Covaxin, India's first vaccine candidate for COVID-19 was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
US Lawmakers Back Covid Chinese Lab Leak Theory After Two-Year Probe New XEC Covid Variant Spreads To 27 Countries, Here's What We Know So Far Study Shows How Long Covid Is Debilitating Children's Health Parents On Mumbai Ferry Wanted To Toss Children In Sea. Rescuers Stopped Them 2 Dead As Saudi Doctor Drives BMW Into Crowded Christmas Market In Germany "Our Recollections Differ": Shashi Tharoor On Hardeep Puri's Soros Claim Delhi Sees Surge In Nursery Admissions For 2025-26 Session US Congress Passes Bill To Avert Government Shutdown Popular Weight Loss Drug Ozempic Could Increase Risk Of Blindness: Study Track Latest News Live on NDTV.com and get news updates from India and around the world.